It is a fair bet to guess that many people taking drugs such as Ozempic are just tired of being fat. The hitch with Ozempic, however, is that is precisely its common purpose.

Obesity medicine could alter the field of orthopedics in 2025, as GLP-1s like Ozempic and Wegovy can help patients lose weight, making them candidates for procedures they previously could not receive, ...

Key Takeaways Novo Nordisk shares rose Wednesday on the company's home market in Denmark and in the U.S. after UBS analysts ...

The Biden administration is expected to release the next batch of drugs that will be subject to Medicare price negotiations — ...

The state’s Independent External Review program launched in January 2024 and took 517 appeals in its inaugural year.

Popular medications, such as Ozempic, Mounjaro and Wegovy, are known as GLP-1 agonists as they mimic the natural GLP-1s ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular ...

A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 484.89% and ...